Hosted on MSN1y
China NMPA grants IND clearance for Fermion’s TYK2 JH2 inhibitor
The China National Medical Products Administration (NMPA) has granted clearance for the investigational new drug (IND) application of Guangzhou Fermion Technology’s FZ007-119. This is the ...
Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China's First SSTR4 Agonist Targeting Pain
Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4.
Ami Organics extends rally on strong Q3 results; stock zooms 30% in 4 days
The management believes, that on account of ramp-up of existing products, Fermion contract, and potential commercialisation ...
BBC4y
The Standard Model Bosons
Bosons are the 'force carrying' or 'force-mediating' particles. If a fermion, such as a quark or lepton produces a boson, which is then taken in by another fermion, then a force exists between the ...
PR Newswire24d
Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China's First SSTR4 Agonist Targeting Pain
GUANGZHOU, China, Jan. 18, 2025 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical ...